pyridoxal phosphate has been researched along with Cirrhosis, Liver in 18 studies
Pyridoxal Phosphate: This is the active form of VITAMIN B 6 serving as a coenzyme for synthesis of amino acids, neurotransmitters (serotonin, norepinephrine), sphingolipids, aminolevulinic acid. During transamination of amino acids, pyridoxal phosphate is transiently converted into pyridoxamine phosphate (PYRIDOXAMINE).
pyridoxal 5'-phosphate : The monophosphate ester obtained by condensation of phosphoric acid with the primary hydroxy group of pyridoxal.
Excerpt | Relevance | Reference |
---|---|---|
" Adverse events were reported for 23% of the patients; most were mild to moderate in intensity, did not require treatment, and were not drug related." | 2.69 | Safety and efficacy of mangafodipir trisodium (MnDPDP) injection for hepatic MRI in adults: results of the U.S. multicenter phase III clinical trials (safety). ( Anderson, MW; Borello, JA; Bova, JG; Brown, JJ; Chezmar, JL; Dachman, AH; Federle, MP; Fenstermacher, M; Foster, GS; Francis, IR; Freeny, PC; Halford, HH; Harmon, B; Harms, SE; Johnson, CD; Kenney, PJ; Klippenstein, DL; Lee, JK; Mattrey, R; Mitchell, DG; Pelsang, RE; Rubin, DL; Saini, S; Semelka, RC; Turner, DA; Weinreb, JC, 2000) |
"Fifty patients with liver cirrhosis and histologically proven HCC were enrolled in a prospective phase-IIIB clinical trial." | 2.69 | MnDPDP-enhanced MRI vs dual-phase spiral CT in the detection of hepatocellular carcinoma in cirrhosis. ( Bartolozzi, C; Cioni, D; Crocetti, L; Donati, F; Lencioni, R, 2000) |
"Intrahepatic thrombus is usually associated with either cirrhosis or hepatocellular carcinoma (HCC)." | 2.68 | Tumoural portal vein thrombosis. Enhancement with MnDPDP. ( Anglade, MC; Coffin, C; Lonjedo, E; Marti-Bonmati, L; Mathieu, D; Poyatos, C, 1997) |
" Adverse events and discomfort were recorded and graded in all patients." | 2.42 | Safety and efficacy of Mangafodipir trisodium in patients with liver lesions and cirrhosis. ( de Beeck, BO; Fagertun, H; Fog, AF; Kane, P; Martí-Bonmatí, L, 2003) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (38.89) | 18.7374 |
1990's | 5 (27.78) | 18.2507 |
2000's | 5 (27.78) | 29.6817 |
2010's | 1 (5.56) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Guéchot, J | 1 |
Boisson, RC | 1 |
Zarski, JP | 1 |
Sturm, N | 1 |
Calès, P | 1 |
Lasnier, E | 1 |
Burkill, GJ | 1 |
King, LJ | 1 |
Scurr, E | 1 |
Healy, JC | 1 |
Martí-Bonmatí, L | 3 |
Fog, AF | 1 |
de Beeck, BO | 1 |
Kane, P | 1 |
Fagertun, H | 1 |
Mitchell, DG | 3 |
Outwater, EK | 1 |
Matteucci, T | 1 |
Rubin, DL | 3 |
Chezmar, JL | 2 |
Saini, S | 3 |
Murakami, T | 1 |
Baron, RL | 1 |
Federle, MP | 2 |
Peterson, MS | 1 |
Oliver, JH | 1 |
Davis, PL | 1 |
Confer, SR | 1 |
Lonjedo, E | 2 |
Mathieu, D | 1 |
Coffin, C | 1 |
Poyatos, C | 2 |
Anglade, MC | 1 |
Casillas, C | 1 |
Weinreb, JC | 1 |
Freeny, PC | 1 |
Semelka, RC | 2 |
Brown, JJ | 2 |
Borello, JA | 1 |
Lee, JK | 2 |
Mattrey, R | 2 |
Dachman, AH | 2 |
Harmon, B | 1 |
Fenstermacher, M | 1 |
Pelsang, RE | 1 |
Harms, SE | 2 |
Halford, HH | 2 |
Anderson, MW | 2 |
Johnson, CD | 1 |
Francis, IR | 1 |
Bova, JG | 1 |
Kenney, PJ | 1 |
Klippenstein, DL | 1 |
Foster, GS | 1 |
Turner, DA | 1 |
Federle, M | 1 |
Chezmar, J | 1 |
Weinreb, J | 1 |
Freeny, P | 1 |
Schmiedl, UP | 1 |
Borrello, JA | 1 |
Bennett, WF | 1 |
Young, SW | 1 |
Rifkin, M | 1 |
Gay, SB | 1 |
Ballerini, R | 1 |
Sherwin, PF | 1 |
Robison, RO | 1 |
Bartolozzi, C | 1 |
Donati, F | 1 |
Cioni, D | 1 |
Crocetti, L | 1 |
Lencioni, R | 1 |
Rossouw, JE | 2 |
Labadarios, D | 2 |
Davis, M | 2 |
Williams, R | 2 |
Jung, K | 1 |
Ohlrich, B | 1 |
Mildner, D | 1 |
Zubek, A | 1 |
Schimmelpfennig, W | 1 |
Egger, E | 1 |
Mitchell, D | 1 |
Wagner, C | 1 |
Stone, WJ | 1 |
Wilkinson, GR | 1 |
Schenker, S | 1 |
Merrill, AH | 3 |
Henderson, JM | 3 |
Scott, SS | 1 |
Hollins, B | 2 |
Kutner, MH | 1 |
Wang, E | 1 |
Codner, MA | 1 |
Millikan, WJ | 1 |
Ohgi, N | 1 |
Hirayama, C | 1 |
2 reviews available for pyridoxal phosphate and Cirrhosis, Liver
Article | Year |
---|---|
Safety and efficacy of Mangafodipir trisodium in patients with liver lesions and cirrhosis.
Topics: Contrast Media; Edetic Acid; Female; Humans; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Magne | 2003 |
Vitamin B6 metabolism by human liver.
Topics: Amino Acids; Humans; Kinetics; Liver; Liver Cirrhosis; Pyridoxal Phosphate; Pyridoxic Acid; Pyridoxi | 1990 |
7 trials available for pyridoxal phosphate and Cirrhosis, Liver
Article | Year |
---|---|
Adrenal gland enhancement at MR imaging with Mn-DPDP.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Contrast Media; Edetic Acid; Female; Humans; Liver | 1995 |
Cirrhosis of the liver: MR imaging with mangafodipir trisodium (Mn-DPDP).
Topics: Case-Control Studies; Contrast Media; Edetic Acid; Female; Humans; Image Processing, Computer-Assist | 1996 |
Tumoural portal vein thrombosis. Enhancement with MnDPDP.
Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Edetic Acid; Female; Humans; Liv | 1997 |
MnDPDP enhancement characteristics and differentiation between cirrhotic and noncirrhotic livers.
Topics: Aged; Chi-Square Distribution; Contrast Media; Edetic Acid; Female; Humans; Liver; Liver Cirrhosis; | 1998 |
Safety and efficacy of mangafodipir trisodium (MnDPDP) injection for hepatic MRI in adults: results of the U.S. multicenter phase III clinical trials (safety).
Topics: Abdominal Pain; Adult; Aged; Aged, 80 and over; Cardiovascular Diseases; Contrast Media; Diagnosis, | 2000 |
Efficacy and safety of mangafodipir trisodium (MnDPDP) injection for hepatic MRI in adults: results of the U.S. Multicenter phase III clinical trials. Efficacy of early imaging.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Diagnosis, Differential; Edetic Acid; Female; Humans | 2000 |
MnDPDP-enhanced MRI vs dual-phase spiral CT in the detection of hepatocellular carcinoma in cirrhosis.
Topics: Carcinoma, Hepatocellular; Edetic Acid; Female; Follow-Up Studies; Humans; Iodized Oil; Liver Cirrho | 2000 |
9 other studies available for pyridoxal phosphate and Cirrhosis, Liver
Article | Year |
---|---|
AST/ALT ratio is not an index of liver fibrosis in chronic hepatitis C when aminotransferase activities are determinate according to the international recommendations.
Topics: Alanine Transaminase; Aspartate Aminotransferases; Biopsy, Fine-Needle; Female; Hepatitis C, Chronic | 2013 |
Breast carcinoma metastases to the liver simulating cirrhosis.
Topics: Breast Neoplasms; Carcinoma, Ductal, Breast; Contrast Media; Edetic Acid; Female; Humans; Liver Cirr | 2002 |
Vitamin B6 and aspartate aminotransferase activity in chronic liver disease.
Topics: Aspartate Aminotransferases; Chronic Disease; Humans; Liver Cirrhosis; Liver Diseases; Necrosis; Pyr | 1978 |
The apoenzyme of aspartate aminotransferase and alanine aminotransferase in the serum of healthy persons and patients suffering from liver diseases.
Topics: Alanine Transaminase; Apoenzymes; Apoproteins; Aspartate Aminotransferases; Enzyme Activation; Femal | 1978 |
Abnormal regulation of plasma pyridoxal 5'-phosphate in patients with liver disease.
Topics: Acute Disease; Adult; Hepatitis, Viral, Human; Humans; Liver Cirrhosis; Liver Diseases; Liver Functi | 1976 |
Pyridoxine deficiency in severe liver disease [proceedings].
Topics: Alcoholism; Ascorbic Acid; Ascorbic Acid Deficiency; Avitaminosis; Humans; Liver Cirrhosis; Pyridoxa | 1976 |
Vitamin B6 repletion in cirrhosis with oral pyridoxine: failure to improve amino acid metabolism.
Topics: Amino Acids; Female; Humans; Liver Cirrhosis; Male; Methionine; Pyridoxal Phosphate; Pyridoxine | 1989 |
Activities of the hepatic enzymes of vitamin B6 metabolism for patients with cirrhosis.
Topics: Adult; Aged; Aldehyde Oxidoreductases; Female; Humans; Liver Cirrhosis; Male; Middle Aged; Phosphori | 1986 |
Vitamin B6 status in cirrhotic patients in relation to apoenzyme of serum alanine aminotransferase.
Topics: Alanine Transaminase; Apoenzymes; Apoproteins; Female; Humans; Liver Cirrhosis; Liver Cirrhosis, Alc | 1988 |